A Prospective Randomized Trial to Assess PO Versus IV Antibiotics for the Treatment of Post-op Wound Infection After Extremity Fractures (POvIV)

Status: Completed
Location: See all (24) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this study is to evaluate the effect of treatment of post-op wound infection in long bones after fracture fixation or joint fusion and either: (Group 1) operative debridement and PO antibiotic treatment for 6 weeks; or (Group 2) operative debridement and IV antibiotics for 6 weeks. Primary Hypothesis 1: The rate of study injury related surgical interventions by one year in Group 1 will be non-inferior to the rate in Group 2. Secondary Hypothesis 1: The rate of treatment failure by one year in Group 1 will be non-inferior to the rate in Group 2. Treatment failure is defined as wound problems that require surgery \>2 weeks after initial debridement, infection recurrence, infection with a new pathogen, joint erosion, implant failure, medical problems related to the treatment administration which necessitates a switch from one arm to the other. Secondary Hypothesis 2: The rate of re-hospitalization for complications, infection, non-union and amputation by one year in Group 1 will be non-inferior to the rate in Group 2. Secondary Hypothesis 3: Following discharge for treatment of infection, per patient treatment costs at 1 year will be lower in Group 1 than in Group 2. Secondary Hypothesis 4: Adherence in Group 1 will be non-inferior to adherence in Group 2. Secondary Hypothesis 5: Patient satisfaction with treatment in Group 1 will be non-inferior to adherence in Group 2. Specific Aim 2: To build and validate a risk prediction model for failure of treatment of early post-op wound infections after fixation of fractures and joint fusions.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 84
Healthy Volunteers: f
View:

• Patients with any fractures of any bone at or proximal to and including the tarsal/metatarsal joint (Lisfranc) or proximal to the carpal joints (includes distal radius fractures), excluding the spine, treated with any type of internal fixation, or

• Patients undergoing fusion of any bone at or proximal to and including the subtalar joint or radial carpal joint, (excluding the spine) that develop a post op wound infection at any time.

• Patients diagnosed with a wound infection of the study injury, defined as patients with at least one of the following:

∙ Deep culture positive after operative debridement.

‣ Cultures positive in thio only after operative debridement.

‣ Negative culture after operative debridement if wound infection meets the Center for Disease control and Prevention (CDC) criteria.

• Patients who are English or Spanish competent.

• Patients aged 18 - 84.

• Patients with bacteria susceptible to both PO and IV antibiotics.

• Patients able to be treated for their infection at the METRC facility for at least 12 months following definitive surgical procedure

• Patients may have multiple eligible study-eligible injuries.

• Patients may have temporary external fixation prior to definitive fixation.

⁃ Patients may have received antibiotics prior to operative wound debridement.

⁃ Patient is able to obtain study medication(s).

⁃ Patient may be pregnant at the time of screening.

Locations
United States
Alabama
University of Alabama at Birmingham
Birmingham
California
Cedars Sinai Medical Center
Los Angeles
University of California at San Francisco
San Francisco
Colorado
Denver Health and Hospital Authority
Denver
Florida
University of Miami Ryder Trauma Center
Miami
Iowa
University of Iowa Hospitals & Clinics
Iowa City
Indiana
Eskenazi Health
Indianapolis
Massachusetts
Boston Medical Center
Boston
Maryland
University of Maryland R Adams Cowley Shock Trauma Center
Baltimore
Minnesota
Hennepin County Medical Center
Minneapolis
Missouri
St. Louis University Medical Center
Saint Louis
North Carolina
Carolinas Medical Center
Charlotte
Wake Forest Baptist Medical Center
Winston-salem
New York
Jamaica Hospital Medical Center
Jamaica
NYU Langone Medical Center
New York
Ohio
MetroHealth Medical Center
Cleveland
Pennsylvania
Penn State University M.S. Hershey Medical Center
Hershey
Tennessee
Vanderbilt University Medical Center
Nashville
Texas
San Antonio Military Medical Center (SAMMC)
San Antonio
Virginia
University of Virginia
Charlottesville
Inova Fairfax Hospital
Falls Church
Naval Medical Center Portsmouth
Portsmouth
Washington
University of Washington/Harborview Medical Center
Seattle
Wisconsin
University of Wisconsin
Madison
Time Frame
Start Date: 2013-12-03
Completion Date: 2020-12-30
Participants
Target number of participants: 233
Treatments
Active_comparator: Oral Antibiotic
Oral Antibiotic Arm; Participants assigned to this group will receive oral antibiotics as prescribed by their treating physician.
Active_comparator: IV Antibiotic
Participants assigned to this group will receive intravenous (IV) antibiotics as prescribed by their treating physician.
Sponsors
Leads: Major Extremity Trauma Research Consortium

This content was sourced from clinicaltrials.gov